An initiative of IBA Proton Therapy
Campus your proton
therapy community
  • Resource center
  • Training
  • Events
  • About
  • Log in
  • Resource center
  • Training
  • Events
  • About
  • Log in
An initiative of IBA Proton Therapy

Your results for

Filter by

Filter by
Results

Filter by

Content type
  • Event - Do not use (0)
  • Podcast (0)
  • Publications (21)
  • Training (0)
  • User case (0)
  • User meeting (0)
  • Webinar (2)
  • White paper (0)
Key content topics
Key audience
  • Newcomers (0)
Top cancer treatments
  • Brain and CNS (4)
  • Breast (3)
  • Gastro-intestinal (7)
  • Genito-urinary (2)
  • Gynecological (0)
  • (-) Head and neck (23)
  • Hodgkin and Non-Hodgkin lymphoma (1)
  • Ocular (0)
  • Pediatric (1)
  • Reirradiation (1)
  • Sarcomas (0)
  • Thoracic (10)
  • Reset filters
  • (-) IMPT
  • (-) Head and neck

Single-institution clinical experience using robust intensity modulated proton therapy in chordoma and chondrosarcoma of the mobile spine and sacrum: Feasibility and need for plan adaptation.

11/11/2021
/ Publications
/
IMPT

Treatment and acute toxicity data of 17 chordoma and 3 chondrosarcoma patients treated with IMPT were retrospectively evaluated in this study. This study found...

A comparison of acute toxicities and patient-reported outcomes between intensity-modulated proton therapy and volumetric-modulated arc therapy after ipsilateral radiation for head and neck cancers.

12/12/2021
/ Publications
/
IMPT
VMAT

A cohort of tonsil and salivary gland cancer patients who received ipsilateral curative-intent radiotherapy delivered by IMPT or VMAT were reviewed including...

Intensity-modulated proton radiation therapy as a radical treatment modality for nasopharyngeal carcinoma in China: A cost-effectiveness analysis.

26/11/2021
/ Publications
/
IMPT
IMRT

This is a cost-effectiveness study from China. A Markov model is used with the assumption that IMPT offered NTCP reduction in long-term dysphagia, xerostomia...

Model-based for nasopharyngeal carcinoma (Spanish subtitles)

31/08/2020
/ Webinar
/
Model-based approach
IMPT
VMAT
ARC therapy

Prof. Hans Langendijk presents the model-based selection procedure for nasopharyngeal carcinoma, IMPT treatment results compared with IMRT or VMAT treatments...

Post-Irradiation Sinus Mucosa Disease in Nasopharyngeal Carcinoma Patients Treated with Intensity-Modulated Proton Therapy.

07/01/2022
/ Publications
/
IMPT
VMAT

This study by the researchers from Taiwan compared the incidence and severity of chronic rhinosinusitis (CRS) in NPC patients who were treated with IMPT (n=53)...

Pencil-beam scanning proton therapy for the treatment of glomus jugulare tumours.

13/08/2022
/ Publications
/
IMPT
Pencil Beam Scanning - PBS

This study by the group from Prague, Czech Republic, reported early outcomes of 12 patients with glomus jugulare tumours (GJT) treated with IMPT to a median...

Model-based for nasopharyngeal carcinoma

24/09/2020
/ Webinar
/
Model-based approach
VMAT
ARC therapy
IMRT
IMPT

Comparing the oncologic outcomes of proton therapy and intensity-modulated radiation therapy for head and neck squamous cell carcinoma.

08/04/2024
/ Publications
/
IMRT
IMPT

To compare the oncologic outcomes between proton therapy and intensity-modulated radiation therapy (IMRT) for head and neck squamous cell carcinoma (HNSCC)...

Longitudinal Assessment of Quality of Life in Nasopharyngeal Cancer Patients Treated with Intensity-Modulated Proton Therapy and Volumetric Modulated Arc Therapy at Different Time Points.

06/05/2024
/ Publications
/
IMPT
Quality of life
VMAT

This is a longitudinal assessment of QoL on 287 NPC patients treated with IMPT (n=41) and VMAT (n=246). Both groups exhibited improved scores of global QoL...

Toxicity Profiles and Survival Outcomes Among Patients With Nonmetastatic Nasopharyngeal Carcinoma Treated With Intensity-Modulated Proton Therapy vs Intensity-Modulated Radiation Therapy.

14/06/2021
/ Publications
/
Toxicity
Survival
IMPT

Seventy-seven patients with nonmetastatic NPC received IMPT (n=28) or IMRT(n=49). With a median follow-up time of 30.3 months, IMPT was associated with lower...

Pagination

  • Previous page ‹
    • Page 1
    • Current page 2
    • Page 3
  • Next page ›
Campus
Subscribe to our newsletter
Follow us on
  • Facebook
  • Linkedin
  • Twitter
  • Youtube
Contact us
  • About Campus
  • Resources
  • Training
  • Connect
  • IBA Worldwide
  • Back to IBA Proton Therapy
Life Science
  • Legal
  • Terms of Use
  • Privacy policy
  • Cookies policy
  • Manage cookies
  • Code of conduct

Cookies policy

If you continue browsing this website, you agree to the use of cookies in order to provide you with services and offers tailored to your own interests.

Manage your cookie preferences

Respect for your privacy is still a priority for us at IBA.

Functional cookies ensure that the website runs smoothly. They cannot be turned off. By setting your preferences, you can turn the use of these cookies on and off on our website, although these settings will only be valid on the device you are currently using.

Accept all cookies
Adapt my preferences
Cookies policies